BIONET Corp. (1784.TWO)

TWD 68.7

(0.15%)

EBITDA Summary of BIONET Corp.

  • BIONET Corp.'s latest annual EBITDA in 2023 was 147.09 Million TWD , up 26.99% from previous year.
  • BIONET Corp.'s latest quarterly EBITDA in 2024 Q2 was 36.84 Million TWD , down -16.52% from previous quarter.
  • BIONET Corp. reported an annual EBITDA of 113.96 Million TWD in 2022, up 45.03% from previous year.
  • BIONET Corp. reported an annual EBITDA of 80.41 Million TWD in 2021, up 76.96% from previous year.
  • BIONET Corp. reported a quarterly EBITDA of 36.84 Million TWD for 2024 Q2, down -16.52% from previous quarter.
  • BIONET Corp. reported a quarterly EBITDA of 17.66 Million TWD for 2023 Q4, down -45.71% from previous quarter.

Annual EBITDA Chart of BIONET Corp. (2023 - 2019)

Historical Annual EBITDA of BIONET Corp. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 147.09 Million TWD 26.99%
2022 113.96 Million TWD 45.03%
2021 80.41 Million TWD 76.96%
2020 44.81 Million TWD 31.47%
2019 34.7 Million TWD 0.0%

Peer EBITDA Comparison of BIONET Corp.

Name EBITDA EBITDA Difference
DIVA Laboratories, Ltd. 100.31 Million TWD -46.631%
Genetics Generation Advancement Corp. 50.6 Million TWD -190.681%
Welgene Biotech Co.,Ltd. 26.83 Million TWD -448.12%
Puriblood Medical Co., Ltd. -44.01 Million TWD 434.187%
TFBS Bioscience Inc. 64.15 Million TWD -129.29%